When transgenic mice that expressed human sickle hemoglobin were mated
with mice having knockout mutations of the mouse alpha-and beta-globi
n genes, animals were produced that synthesized only human hemoglobin
in adult red blood cells. Similar to many human patients with sickle c
ell disease, the mice developed a severe hemolytic anemia and extensiv
e organ pathology. Numerous sickled erythrocytes were observed in peri
pheral blood. Although chronically anemic, most animals survived for 2
to 9 months and were fertile. Drug and genetic therapies can now be t
ested in this mouse model of sickle cell disease.